Article
Version 1
Preserved in Portico This version is not peer-reviewed
Identification and Molecular Characterization of the Human GcMAF Receptor
Version 1
: Received: 7 June 2024 / Approved: 7 June 2024 / Online: 7 June 2024 (08:25:12 CEST)
Version 2 : Received: 21 June 2024 / Approved: 21 June 2024 / Online: 21 June 2024 (08:11:03 CEST)
Version 2 : Received: 21 June 2024 / Approved: 21 June 2024 / Online: 21 June 2024 (08:11:03 CEST)
A peer-reviewed article of this Preprint also exists.
Ruggiero, M. (2024). Identification and Molecular Characterization of the Human GcMAF Receptor. Ruggiero, M. (2024). Identification and Molecular Characterization of the Human GcMAF Receptor.
Abstract
This study proposes the first extracellular domain (residues 1-34) of the CCR1 protein as the Gc protein-derived Macrophage Activating Factor (GcMAF) receptor. The CCR1 gene, expressed in monocytes and 168 other cell types or tissues, encodes this transmembrane protein. Electrostatic and hydrophobic interactions, along with hydrogen bonds mediate the molecular interactions between the TPT420-GalNAcELAK (or TPK420ELAK) sequences of GcMAF (or Gc2 protein variant) and the TTEDYDTTT sequence of its receptor.
Keywords
GcMAF; receptor; immune system; cancer; autism; COVID-19
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment